跳至主要内容
临床试验/NCT02008448
NCT02008448Unknown2 期

Endomyocardial Botulinum Toxin Injection in Patients With Persistent Atrial Fibrillation

Meshalkin Research Institute of Pathology of Circulation2 个研究点 分布在 2 个国家目标入组 160 人开始时间: 2013年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
发起方
入组人数
160
试验地点
2
主要终点
freedom of atrial tachyarrhythmia, including AF and atrial flutter/tachycardia

研究概览

简要总结

The investigators have conducted a prospective, double-blind, randomized study to assess the comparative safety and efficacy of two different ablation strategies, PVI plus linear lesions (LL) plus botulinum toxin injection versus PVI plus linear lesions (LL), in patients with persistent or longstanding persistent AF. Results were assessed with the use of an implanted monitoring device (IMD).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Persistent and longstanding persistent AF

排除标准

  • congestive heart failure
  • LV ejection fraction < 35%
  • left atrial diameter > 60 mm

研究组 & 干预措施

PVI+LL

Active Comparator

Circumferential PVI was accomplished and then additional ablation lines were created by connecting the left inferior PV to the mitral annulus (mitral isthmus) and the LA between the two superior PVs (roof). Finally, patients underwent cavo-tricuspid isthmus ablation in the right atrium.

干预措施: Pulmonary vein isolation (Procedure)

PVI+LL

Active Comparator

Circumferential PVI was accomplished and then additional ablation lines were created by connecting the left inferior PV to the mitral annulus (mitral isthmus) and the LA between the two superior PVs (roof). Finally, patients underwent cavo-tricuspid isthmus ablation in the right atrium.

干预措施: Linear Lesion Ablation (Procedure)

PVI+LL+BT injection

Active Comparator

Circumferential PVI was accomplished and then additional ablation lines were created by connecting the left inferior PV to the mitral annulus (mitral isthmus) and the LA between the two superior PVs (roof). Finally, patients underwent cavo-tricuspid isthmus ablation in the right atrium.

Injection of the botulinum toxin is performed in main anatomical zones of ganglionated plexuses of left atrium using Myostar catheter (Biosense Webster).

干预措施: Pulmonary vein isolation (Procedure)

PVI+LL+BT injection

Active Comparator

Circumferential PVI was accomplished and then additional ablation lines were created by connecting the left inferior PV to the mitral annulus (mitral isthmus) and the LA between the two superior PVs (roof). Finally, patients underwent cavo-tricuspid isthmus ablation in the right atrium.

Injection of the botulinum toxin is performed in main anatomical zones of ganglionated plexuses of left atrium using Myostar catheter (Biosense Webster).

干预措施: Linear Lesion Ablation (Procedure)

PVI+LL+BT injection

Active Comparator

Circumferential PVI was accomplished and then additional ablation lines were created by connecting the left inferior PV to the mitral annulus (mitral isthmus) and the LA between the two superior PVs (roof). Finally, patients underwent cavo-tricuspid isthmus ablation in the right atrium.

Injection of the botulinum toxin is performed in main anatomical zones of ganglionated plexuses of left atrium using Myostar catheter (Biosense Webster).

干预措施: BT injection (Drug)

结局指标

主要结局

freedom of atrial tachyarrhythmia, including AF and atrial flutter/tachycardia

时间窗: 1 year

次要结局

  • serious adverse events(1 year)

研究者

发起方
Meshalkin Research Institute of Pathology of Circulation
申办方类型
Network
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验